Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2025-12-25 @ 3:33 AM
NCT ID:
NCT00530205
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosed with stage III non-small cell lung cancer (NSCLC)
* Plan to begin radiotherapy for NSCLC
* Radiotherapy is the only planned therapy for this cancer
* No brain metastases
PATIENT CHARACTERISTICS:
Inclusion criteria:
* Must be able to stand without assistance
Exclusion criteria:
* Unable to comply with study requirements
* Native language other than American English
* Pacemaker or implanted defibrillator
PRIOR CONCURRENT THERAPY:
Exclusion criteria:
* Receiving chemotherapy in combination with radiotherapy
* Concurrent megace or steroids
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT00530205
Study Brief:
Protocol Section:
NCT00530205